Loading company…
Cambridge-based Potenza Therapeutics is a biopharmaceutical company developing therapies for chronic illnesses.
Founded in 2013 in Cambridge, US, Potenza Therapeutics, Inc. develops biopharmaceuticals for chronic conditions, with a focus on personalized medicine sold to hospitals, clinics and specialty care providers. Astellas Pharma acquired the company in December 2018 for up to USD 404.7 mn, including an upfront payment of USD 164.6 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in